SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001193805-21-000573
Filing Date
2021-04-29
Accepted
2021-04-29 17:42:08
Documents
2
Period of Report
2021-04-29

Document Format Files

Seq Description Document Type Size
1 e620538_3-wti.html 3  
1 e620538_3-wti.xml 3 8040
2 e620538_ex99.htm EX-99 5355
  Complete submission text file 0001193805-21-000573.txt   16823
Mailing Address 345 PARK AVENUE SOUTH, 12TH FLOOR NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH, 12TH FLOOR NEW YORK NY 10010 2125511600
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (Reporting) CIK: 0001009258 (see all company filings)

State of Incorp.: DE
Type: 3 | Act: 34 | File No.: 001-40366 | Film No.: 21872438

Mailing Address 780 THIRD AVENUE 37TH FLOOR NEW YORK NY 10017
Business Address 780 THIRD AVENUE 37TH FLOOR NEW YORK NY 10017 2125511600
Deerfield Mgmt L.P. (Reporting) CIK: 0001010823 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40366 | Film No.: 21872439

Mailing Address 345 PARK AVENUE SOUTH 12TH FLOOR NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH 12TH FLOOR NEW YORK NY 10010 212-551-1600
DEERFIELD PARTNERS, L.P. (Reporting) CIK: 0001301041 (see all company filings)

State of Incorp.: DE
Type: 3 | Act: 34 | File No.: 001-40366 | Film No.: 21872437

Mailing Address 780 THIRD AVENUE 37TH FLOOR NEW YORK NY 10017
Business Address
Flynn James E (Reporting) CIK: 0001352546 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40366 | Film No.: 21872440

Mailing Address 1030 MASSACHUSETTS AVENUE SUITE 210 CAMBRIDGE MA 02138
Business Address 1030 MASSACHUSETTS AVENUE SUITE 210 CAMBRIDGE MA 02138 617-952-0555
Werewolf Therapeutics, Inc. (Issuer) CIK: 0001785530 (see all company filings)

IRS No.: 823523180 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations